Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$861,974
+$41,634 QoQ
Shares Held
3,394
+1.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#3,158
of 4,676 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Carr Financial Group Corp holds $8,711,748 across 6 Drug Manufacturers - General names. JNJ ranks #4 (9.9% of the industry book) .
All Filings in JNJ
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $861,974 | 3,394 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $820,340 | 3,356 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $602,638 | 2,912 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $539,015 | 2,907 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $535,083 | 3,503 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $577,620 | 3,483 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $504,289 | 3,487 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $652,777 | 4,028 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $509,367 | 3,485 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $548,286 | 3,466 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $602,351 | 3,843 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $597,457 | 3,836 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $671,183 | 4,055 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $641,390 | 4,138 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $773,020 | 4,376 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||